GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Shen Lian Biomedical Corp (SHSE:688098) » Definitions » Ending Cash Position

Shanghai Shen Lian Biomedical (SHSE:688098) Ending Cash Position : ¥40.8 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Shen Lian Biomedical Ending Cash Position?

Shanghai Shen Lian Biomedical's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥40.8 Mil.

Shanghai Shen Lian Biomedical's quarterly Ending Cash Position increased from Sep. 2023 (¥38.9 Mil) to Dec. 2023 (¥44.8 Mil) but then declined from Dec. 2023 (¥44.8 Mil) to Mar. 2024 (¥40.8 Mil).

Shanghai Shen Lian Biomedical's annual Ending Cash Position increased from Dec. 2021 (¥44.1 Mil) to Dec. 2022 (¥52.5 Mil) but then declined from Dec. 2022 (¥52.5 Mil) to Dec. 2023 (¥44.8 Mil).

Shanghai Shen Lian Biomedical Ending Cash Position Historical Data

The historical data trend for Shanghai Shen Lian Biomedical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Shen Lian Biomedical Ending Cash Position Chart

Shanghai Shen Lian Biomedical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 155.77 113.54 44.15 52.55 44.84

Shanghai Shen Lian Biomedical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.73 148.82 38.88 44.84 40.81

Shanghai Shen Lian Biomedical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Shanghai Shen Lian Biomedical's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=52.545+-7.704
=44.8

Shanghai Shen Lian Biomedical's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=44.841+-4.035
=40.8

Shanghai Shen Lian Biomedical Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Shanghai Shen Lian Biomedical's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Shen Lian Biomedical (SHSE:688098) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Shen Lian Biomedical Corp (SHSE:688098) » Definitions » Ending Cash Position
Comparable Companies
SHSE:688426 SHSE:688253 SZSE:002286 SHSE:688399 SHSE:688265 SHSE:688767 SZSE:300966 SZSE:301258 SZSE:002873 SZSE:000518 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 48, Jiangchuan East Road, Minhang District, Shanghai, CHN, 200241
Website
http://www.slbio.com.cn
Shanghai Shen Lian Biomedical Corp is engaged in the development, production and sales of veterinary biological products.
Executives
Ma Gui Jun Core technical personnel
Gao Yan Chun senior management

Shanghai Shen Lian Biomedical (SHSE:688098) Headlines

No Headlines